Global Status Report for the Verification of Measles and Rubella Elimination, 2022.

IF 5.2 3区医学 Q1 IMMUNOLOGY Vaccines Pub Date : 2024-08-22 DOI:10.3390/vaccines12080947

Patrick O'Connor, Balcha Masresha, Desirée Pastor, Nasrin Musa, José Hagan, Sudhir Khanal, Chung-Won Lee, Natasha Crowcroft

{"title":"Global Status Report for the Verification of Measles and Rubella Elimination, 2022.","authors":"Patrick O'Connor, Balcha Masresha, Desirée Pastor, Nasrin Musa, José Hagan, Sudhir Khanal, Chung-Won Lee, Natasha Crowcroft","doi":"10.3390/vaccines12080947","DOIUrl":null,"url":null,"abstract":"<p><p>Since the World Health Assembly (WHA) in 2012 endorsed the Global Vaccine Action Plan (GVAP), which included regional measles and rubella elimination goals by 2020, global progress towards verification of measles and rubella elimination has been incremental. Even though the 2020 elimination goals were not achieved, commitment towards achieving measles and rubella elimination has been firmly established in the Immunization Agenda 2030 (IA2030) and the Measles and Rubella Strategic Framework (MRSF) 2021-2030. In 2023, the six Regional Verification Commissions for measles and rubella elimination (RVCs) reviewed data as of 31 December 2022 and confirmed that 82 (42%) Member States have been verified for measles elimination, and 98 (51%) Member States have been verified for rubella elimination. The six RVCs are composed of independent public health and immunization experts who are well-placed to support accelerating measles and rubella elimination. RVCs should be leveraged not only to review elimination documents but also to advocate for and champion public health programming that supports measles and rubella activities. The verification of elimination process is one of many tools that should be deployed to reinforce and accelerate efforts towards achieving a world free of measles and rubella.</p>","PeriodicalId":23634,"journal":{"name":"Vaccines","volume":null,"pages":null},"PeriodicalIF":5.2000,"publicationDate":"2024-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11359695/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vaccines","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/vaccines12080947","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Since the World Health Assembly (WHA) in 2012 endorsed the Global Vaccine Action Plan (GVAP), which included regional measles and rubella elimination goals by 2020, global progress towards verification of measles and rubella elimination has been incremental. Even though the 2020 elimination goals were not achieved, commitment towards achieving measles and rubella elimination has been firmly established in the Immunization Agenda 2030 (IA2030) and the Measles and Rubella Strategic Framework (MRSF) 2021-2030. In 2023, the six Regional Verification Commissions for measles and rubella elimination (RVCs) reviewed data as of 31 December 2022 and confirmed that 82 (42%) Member States have been verified for measles elimination, and 98 (51%) Member States have been verified for rubella elimination. The six RVCs are composed of independent public health and immunization experts who are well-placed to support accelerating measles and rubella elimination. RVCs should be leveraged not only to review elimination documents but also to advocate for and champion public health programming that supports measles and rubella activities. The verification of elimination process is one of many tools that should be deployed to reinforce and accelerate efforts towards achieving a world free of measles and rubella.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

2022 年全球消除麻疹和风疹情况核查报告》。

世界卫生大会（WHA）于 2012 年批准了《全球疫苗行动计划》（GVAP），其中包括到 2020 年消除麻疹和风疹的区域目标。尽管 2020 年消除麻疹和风疹的目标没有实现，但《2030 年免疫议程》（IA2030）和《2021-2030 年麻疹和风疹战略框架》（MRSF）坚定地确立了实现消除麻疹和风疹的承诺。2023 年，六个消除麻疹和风疹地区核查委员会（RVCs）审查了截至 2022 年 12 月 31 日的数据，确认 82 个（42%）会员国已通过消除麻疹核查，98 个（51%）会员国已通过消除风疹核查。六个区域核查中心由独立的公共卫生和免疫接种专家组成，他们完全有能力支持加快消除麻疹和风疹的工作。区域联络点不仅应被用来审查消除麻疹和风疹的文件，还应倡导和支持支持麻疹和风疹活动的公共卫生计划。消除麻疹和风疹核查程序是众多工具中的一种，应利用这些工具加强和加快实现世界无麻疹和风疹的努力。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Vaccines Pharmacology, Toxicology and Pharmaceutics-Pharmacology

CiteScore

8.90

自引率

16.70%

发文量

1853

审稿时长

18.06 days

期刊介绍： Vaccines (ISSN 2076-393X) is an international, peer-reviewed open access journal focused on laboratory and clinical vaccine research, utilization and immunization. Vaccines publishes high quality reviews, regular research papers, communications and case reports.